160564-65-8

Basic information

• Product Name: Benzenamine, 2-fluoro-6-(phenylmethoxy)-
• CAS NO: 160564-65-8
• Molecular Formula: C13H12FNO
• Molecular Weight: 217.243
• Mol File: 160564-65-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzenamine, 2-fluoro-6-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 2-fluoro-6-(phenylmethoxy)-(160564-65-8)
• EPA Substance Registry System: Benzenamine, 2-fluoro-6-(phenylmethoxy)-(160564-65-8)

Safety Data

• Hazardous Substances Data: 160564-65-8(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 385-01-3 2-nitro-3-fluorophenol 
• 100-51-6 benzyl alcohol 
• 19064-24-5 2,6-difluoro-1-nitrobenzene 
• 920284-79-3 1-(benzyloxy)-3-fluoro-2-nitrobenzene 

Downstream Products

• 53981-23-0 2-amino-3-fluorophenol 
• 186309-73-9 2-amino-5-bromo-3-fluorophenol 
• 941608-35-1 methanesulfonic acid 2-[3-benzyloxy-5-fluoro-4-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)-benzyl]-5-methylphenyl ester 
• 941608-33-9 5-(2-benzyloxy-6-fluoro-4-iodophenyl)-2-benzyloxymethyl-1,1-dioxo-1,2,5-thiadiazolidin-3-one 
• 941608-29-3 methyl 2-((2-(benzyloxy)-4-bromo-6-fluorophenyl)(N-(tert-butoxycarbonyl)sulfamoyl)amino)acetate 
• 941608-45-3 N-(t-butoxycarbonylsulfamoyl)-N-(2-benzyloxy-6-fluorophenyl)glycine methyl ester 
• 941608-32-8 5-(2-benzyloxy-6-fluoro-4-iodophenyl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one 
• 941608-30-6 methyl 2-((2-(benzyloxy)-4-bromo-6-fluorophenyl)(sulfamoyl)amino)acetate 
• 941608-46-4 N-sulfamoyl-N-(2-benzyloxy-6-fluorophenyl)glycine methyl ester 
• 1227745-28-9 (6-benzyloxy-3-bromo-2-fluorophenyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

DIAMINOTRIAZINE COMPOUNDS

The present invention relates to diaminotriazine compounds and to their use as herbicides. It also relates to agrochemical compositions for crop protection and to a method for controlling unwanted vegetation.

1-ORTHOFLUOROPHENYL SUBSTITUTED 1, 2 , 5-THIAZOLIDINEDIONE DERIVATIVES AS PTP-AS INHIBITORS

Compounds of the formula (I) are inhibitors of protein tyrosine phosphatases (PTPases) and, thus, may be employed for the treatment of conditions mediated by PTPase activity. The compounds of the present invention may also be employed as inhibitors of other enzymes characterized with a phosphotyrosine binding region such as the SH2 domain. Accordingly, the compounds of formula (I) may be employed for prevention and/or treatment of insulin resistance associated with obesity, glucose intolerance, diabetes mellitus, hypertension and ischemic diseases of the large and small blood vessels, conditions that accompany type-2 diabetes, including hyperlipidemia, hypertriglyceridemia, atherosclerosis, vascular restenosis, irritable bowel syndrome, pancreatitis, adipose cell tumors and carcinomas such as liposarcoma, dyslipidemia, and other disorders where insulin resistance is indicated. In addition, the compounds of the present invention may be employed to treat and/or prevent cancer, osteoporosis, neurodegenerative and infectious diseases, and diseases involving inflammation and the immune system.

N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS

Compounds of formula B-C-A-CO-NH-R1, wherein A is structure i, ii or iii: formulae (I), (II), (III). C is optionally substituted aryl or heteroaryl, and B is a specified cyclic moiety, or C and B together are a heterobicyclic moiety, are useful as antibacterial agents.